#KIDNEY trial: #RenalGuard automated diuresis significantly reduces #AKI after #cardiac surgery. #Post-opAKI significantly lower in RenalGuard group vs. standard hydration, 10% vs. 20.9%. #ASN#kidneywk
Late-breaking #KIDNEY#clintrial results this morning at 10:00, Exhibit Halls/AB. #AKI prevalent in cardiac surgery, occurring in 30 percent of cases and 50-70 percent of emergent cases. Can it be reduced? Poster TH-PO1183. #ASN#kidneywk
Hope to see you tomorrow 10:00 am; #latebreaking#clintrial TH-PO1183. Kidney protection using the #RenalGuard System in Cardiac Surgery (KIDNEY Study)…assessing #AKI rates; randomized controlled 220-patient trial. #ASN#kidneywk
REMEDIAL III slides presented at #TCT2019 outlining a randomized trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration. UFR-guided approach is superior in preventing CI-AKI in high-risk patients.
Full slide deck: https://t.co/sHG3Dr8l1l
Prof. Ponikowski explains why his late-breaking results from ESC-HF make him optimistic about the potential for @RenalGuard system to help decongest heart failure patients w/ fluid overload. #ADHF#heartfailure https://t.co/YlV1WVTJDX
Watch how RenalGuard-Guided Diuretic Therapy is is designed to work for #heartfailure and #AKI patients in our animation video here. #HeartFailure2018
https://t.co/cXVjqOhacJ
We presented #latebreaking data at @escardio#HeartFailure2018 that demonstrated potential benefits of RenalGuard-Guided Diuretic Therapy for #heartfailure. Check out the press release for full details here. https://t.co/lS5VxaN2Uc
The device, the RenalGuard-Guided Diuretic Therapy, was proven to optimize fluid management in acute decompensated heart failure patients while alleviating related symptoms.
https://t.co/NWSCo9FBJw
Cogmedix is proud to have a long standing relationship with RenalGuard Solutions, working with them to manufacture their critical life-saving #MedicalDevices Congratulations to RenalGuard for their recent clinical trial success! https://t.co/EMyqm1wc4x